Red Sox first baseman Triston Casas is 'living my worst nightmare' as he embarks on injury rehab
FILE - Boston Red Sox first baseman Triston Casas walks off the field before a baseball game against the Baltimore Orioles, April 3 2025, in Baltimore. (AP Photo/Daniel Kucin Jr., File)
FILE - Boston Red Sox first baseman Triston Casas walks off the field before a baseball game against the Baltimore Orioles, April 3 2025, in Baltimore. (AP Photo/Daniel Kucin Jr., File)
FILE - Boston Red Sox's Triston Casas is transported off the field on a stretcher after an injury during the second inning of a baseball game against the Minnesota Twins at Fenway Park in Boston, May 2, 2025. (AP Photo/Charles Krupa, File)
FILE - Boston Red Sox first baseman Triston Casas walks off the field before a baseball game against the Baltimore Orioles, April 3 2025, in Baltimore. (AP Photo/Daniel Kucin Jr., File)
BOSTON (AP) — Triston Casas isn't happy about having to watch the remainder of the Boston Red Sox's season following season-ending knee surgery. But he's ready to attack the rehab from his second major injury in two years head on.
Casas spoke to reporters Tuesday for the first time since having the procedure last month to repair the ruptured left patellar tendon he injured running to first base after hitting a slow ground ball and then falling awkwardly during Boston's win over Minnesota on May 2. He was carted off the field and taken to a hospital for testing.
Advertisement
He had surgery two days later.
He was still using crutches Tuesday and said he will be off them soon. He will then head to the Red Sox's spring training facility in Fort Myers, Florida, where he'll spend most of this summer and the offseason undergoing rehab. The 25-year-old plans to be ready in time for opening day next season.
'I'm living my worst nightmare right now to go through a double-digit recovery that's months long,' Casas said Tuesday. 'But going through it now, I feel like I'm going to be better as a consequence of it. It's just part of the game. It's part of running hard down the line. Part of just playing the game how you feel like it should be. I wouldn't have changed anything about it. It's just a move that I've done a thousand times. ... It's just onward from here, I guess.'
The first baseman batted just .182 with three homers and 11 RBIs prior to the injury, but the biggest void he left is on defense. The Red Sox have explored multiple options to replace him, including initially asking Rafael Devers to learn the position after he was replaced at third by offseason, free-agent acquisition Alex Bregman, and moved to DH.
Advertisement
Since Casas' injury, Abraham Toro has split time at first along with Romy Gonzalez.
Casas is attacking this latest injury setback just a year removed from missing a large portion of last season with torn cartilage in his rib cage.
'I'd rather be out there helping the team win games,' Casas said. 'But considering everything that's happened I'm in a good headspace. Just focused on making a healthy comeback and progressing every day in whatever fashion it is and trying to fill my time and get better any way that I can.'
He said the recovery timeline he was given has varied in length, but hasn't been anything over a year.
Advertisement
'As of right now, our goal is opening day next year,' Casas said. 'So, I'm going to take it slow. Going to spend the winter in Fort Myers rehabbing and until then just try to stay in a positive mindset. I know there's a lot of healing that's done outside of the training table. So I think I'm trying to take it one day at a time, be positive and maintain a good headspace is going to be important as well.'
___
AP MLB: https://apnews.com/hub/mlb
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
San Francisco Chronicle
2 hours ago
- San Francisco Chronicle
Pivetta strikes out 10 in combined 4-hitter as the Padres beat the Giants 5-1
SAN DIEGO (AP) — Nick Pivetta allowed a leadoff homer by Jung Hoo Lee and then settled down to tie his season high with 10 strikeouts in six innings and lead the San Diego Padres to a 5-1 victory against the San Francisco Giants on Tuesday night. The Padres snapped a four-game losing streak and remained two games behind the defending World Series champion Los Angeles Dodgers in the NL West. Lee homered to right-center on Pivetta's second pitch. It was his second career leadoff shot and sixth homer of the season. Pivetta (13-4) walked two batters that inning but allowed only three more baserunners, on two hits and a hit batter. He combined on a four-hitter with All-Star relievers Adrian Morejon, Jason Adam and Robert Suarez. Pivetta beat the Giants in consecutive starts, with his most recent outing being an 11-1 win at San Francisco on Aug. 13 during a three-game sweep that helped the Padres take a one-game lead over the Dodgers. The Padres were then swept in a weekend series at Dodger Stadium. The Padres tied it in the bottom of the first when leadoff batter Fernando Tatis Jr. reached on shortstop Christian Koss' throwing error, advanced on Luis Arraez's double and scored on Manny Machado's ground out. The Padres went ahead 3-1 in the fourth when Giants starter Kai-Wei Teng (1-3) had control issues, hitting two batters with pitches to load the bases and then allowing Jose Iglesias' single. Spencer Bivens came on and got a force out before walking Tatis to bring in another run. Key stat Pivetta reached double digits in strikeouts for the 20th time in his career. Up next Giants RHP Landen Roupp (7-6, 3.45) and Padres LHP JP Sears (7-10, 5.12 ERA) are scheduled to start Wednesday night. ___
Yahoo
3 hours ago
- Yahoo
Red Sox strand 13 runners, fall to Baltimore 4-3 in 11 innings
BOSTON (AP) — Samuel Basallo drove in the go-ahead run on a groundout in the 11th inning and the Baltimore Orioles held on to beat the Boston Red Sox 4-3 on Tuesday night after blowing a two-run lead in the ninth. The Orioles won their third straight and for the sixth time in their last seven games, sweeping the two-game series at Boston but needing extra innings after Nathaniel Lowe hit a two-run homer in the bottom of the ninth to tie it. Boston loaded the bases with one out in the 10th before a double play ended the threat. The Red Sox had another opportunity with a runner on third with one out in the 11th but couldn't get him home. The Red Sox went 0 for 13 with runners in scoring position and left 13 on base. Alex Bregman popped out to short to end it, giving Yennier Cano (2-6) the win and Corbin Martin his second save. Garret Whitlock (5-3) allowed the unearned run in the 11th. Ryan Mountcastle had an RBI single and Colton Cowser doubled in another run during the Orioles' three-run fifth inning. Boston took a 1-0 lead in the third when Tomoyuki Sugano was called for a balk with runners on second and third. Boston, which leads the majors in extra-base hits, had seven hits — all singles — before Lowe tied it with his 17th homer of the season and first since signing with Boston on Monday. The Orioles are back home on Thursday for a four-game series against the Houston Astros. Baltimore has not named a starter. The Red Sox open a four-game series at the New York Yankees on Thursday. Boston has not announced a starter for the series opener. Download the FREE Boston 25 News app for breaking news alerts. Follow Boston 25 News on Facebook and Twitter. | Watch Boston 25 News NOW
San Francisco Chronicle
4 hours ago
- San Francisco Chronicle
New malaria drug for babies offers hope to health workers in Uganda
KAMPALA, Uganda (AP) — Alice Nekesa did not know she was infected with malaria-causing parasites until it was too late. She was in the fourth month of pregnancy last year when she started bleeding, a miscarriage later attributed to untreated malaria in her. The Ugandan farmer said recently that she regretted the loss of what would have been her second child 'because I didn't discover malaria and treat it early.' Variations of such cases are commonly reported by Ugandan health workers who witness stillbirths or feverish babies that die within days from undiagnosed malaria. The deaths are part of a wider death toll tied to the mosquito-borne disease, the deadliest across Africa, but one easily treated in adults who seek timely medical care. Until recently, a major gap in malaria treatment was how to care for newborns and infants infected with malaria who weren't strong enough to receive regular medication. That changed last month when Swiss medical regulators approved medicine from the Basel-based pharmaceutical company Novartis for babies weighing between 2 and 5 kilograms (nearly 4½ to 11 pounds). Swissmedic said the treatment, a sweet-tasting tablet that disperses into a syrup when dropped into water, was approved in coordination with the World Health Organization under a fast-track authorization process to help developing countries access much-needed treatment. Africa's 1.5 billion people accounted for 95% of an estimated 597,000 malaria deaths worldwide in 2023, according to the WHO. More than three-quarters of those deaths were among children. In Uganda, an east African country of 45 million people, there were 12.6 million malaria cases and nearly 16,000 deaths in 2023. Many were children younger than 5 and pregnant women, according to WHO. Nigeria, Congo and Uganda — in that order — are the African countries most burdened by malaria, a parasitic disease transmitted to humans through the bites of infected mosquitoes that thrive and breed in stagnant water. The drug approved by Swiss authorities, known as Coartem Baby in some countries and Riamet Baby in others, is a combination of two antimalarials. It is a lower dose version of a tablet previously approved for other age groups, including for older children. Before Coartem Baby, antimalarial drugs designed for older children were administered to small infants with careful adjustments to avoid overdose or toxicity. Ugandan authorities, who have been working to update clinical guidelines for treating malaria, say the new drug will be rolled out as soon as possible. It is not yet available in public hospitals. The development of Coartem Baby has given hope to many, with local health workers and others saying the medicine will save the lives of many infants. Ronald Serufusa, the top malaria official for the district of Wakiso, which shares a border with the Ugandan capital of Kampala, said he believes Coartem Baby will be available 'very, very soon' and that one priority is sensitizing the people adhering to treatment. Some private pharmacies already have access to Coartem Baby, 'flavored with orange or mango' to make it palatable for infants, he said. During the so-called malaria season, which coincides with rainy periods twice a year, long lines of sick patients grow outside government-run health centers across Uganda. Many are often women with babies strapped to their backs. Health workers now are trained to understand that 'malaria can be implicated among newborns,' even when other dangerous conditions like sepsis are present, Serufusa said. 'If they don't expand their investigations to also suspect malaria, then it goes unnoticed,' he said, speaking of health workers treating babies. The Malaria Consortium, a global nonprofit based in London, in a statement described the approval of Coartem Baby as 'a major leap forward for saving the lives of young children in countries affected by malaria.' In addition to Uganda, the drug will be rolled out in Burkina Faso, Côte d'Ivoire, Kenya, Malawi, Mozambique, Nigeria, and Tanzania, the group said. Jane Nabakooza, a pediatrician with Uganda's malaria control program, said she expects the government will make Coartem Baby available to patients free of charge, even after losing funding when the U.S. shrank its foreign aid program earlier this year. Some malaria funding from outside sources, including the Global Fund to Fight AIDS, Malaria and Tuberculosis, remains available for programs such as indoor spraying to kill mosquitoes that spread the malaria-causing parasite. Because of funding shortages, 'we are focusing on those that are actually prone to severe forms of malaria and malaria deaths, and these are children under 5 years,' she said.
